Literature DB >> 3901257

A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites.

D Camus, T J Hadley.   

Abstract

Antigens that bind to erythrocytes were identified in the supernatant fluids of a cultured human malaria parasite (Plasmodium falciparum). A 175-kilodalton (175K) antigen bound only to erythrocytes susceptible to invasion. The 175K antigen from the Camp or the FCR-3 strain also bound to merozoites. However, the antigen did not bind to merozoites when merozoites and supernatant antigens were from different strains unless proteinase inhibitors were present. Moreover, erythrocytes coated with supernatant antigens from the Camp or FCR-3 strain were invaded normally by merozoites of the homologous strain but were partially resistant to invasion by merozoites of the heterologous strain. The 175K antigen may be a receptor acting as a "bridge" between erythrocytes and merozoites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3901257     DOI: 10.1126/science.3901257

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  117 in total

1.  Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.

Authors:  L Wang; C G Black; V M Marshall; R L Coppel
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria.

Authors:  Lina Wang; Lukasz Kedzierski; Steven L Wesselingh; Ross L Coppel
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  RAP1 controls rhoptry targeting of RAP2 in the malaria parasite Plasmodium falciparum.

Authors:  D L Baldi; K T Andrews; R F Waller; D S Roos; R F Howard; B S Crabb; A F Cowman
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

4.  Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations.

Authors:  Alexander G Maier; Manoj T Duraisingh; John C Reeder; Sheral S Patel; James W Kazura; Peter A Zimmerman; Alan F Cowman
Journal:  Nat Med       Date:  2002-12-09       Impact factor: 53.440

5.  Invasion profiles of Brazilian field isolates of Plasmodium falciparum: phenotypic and genotypic analyses.

Authors:  Cheryl-Ann Lobo; Karla de Frazao; Marilis Rodriguez; Marion Reid; Mariano Zalis; Sara Lustigman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Quantitative proteomics reveals new insights into erythrocyte invasion by Plasmodium falciparum.

Authors:  Claudia Kuss; Chee Sian Gan; Karthigayan Gunalan; Zbynek Bozdech; Siu Kwan Sze; Peter Rainer Preiser
Journal:  Mol Cell Proteomics       Date:  2011-10-24       Impact factor: 5.911

7.  Human erythrocyte band 3 functions as a receptor for the sialic acid-independent invasion of Plasmodium falciparum. Role of the RhopH3-MSP1 complex.

Authors:  Michael Baldwin; Innocent Yamodo; Ravi Ranjan; Xuerong Li; Gregory Mines; Marina Marinkovic; Toshihiko Hanada; Steven S Oh; Athar H Chishti
Journal:  Biochim Biophys Acta       Date:  2014-08-23

8.  Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies.

Authors:  P H Jakobsen; P M Heegaard; C Koch; K Wasniowska; M M Lemnge; J B Jensen; B K Sim
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Molecular analysis of erythrocyte invasion in Plasmodium falciparum isolates from Senegal.

Authors:  Cameron V Jennings; Ambroise D Ahouidi; Martine Zilversmit; Amy K Bei; Julian Rayner; Ousmane Sarr; Omar Ndir; Dyann F Wirth; Souleymane Mboup; Manoj T Duraisingh
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

10.  Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein.

Authors:  T Tsuboi; S H Kappe; F al-Yaman; M D Prickett; M Alpers; J H Adams
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.